SSTR2 and adenoma: In another study, 15 SCAs demonstrated greater immunoreactive scores for SSTR2 compared with null cell adenomas (defined in that study as hormone-, SF1-, and PIT1-negative samples; n = 10) and greater immunoreactive scores for SSTR5 compared with SGAs (n = 110) (32).